131 related articles for article (PubMed ID: 3137397)
21. The ability of peripheral blood mononuclear cells (PBMC) of syphilitic patients to produce IL-2.
Podwińska J; Zaba R; Chomik M; Bowszyc J
FEMS Immunol Med Microbiol; 1995 Sep; 12(1):17-27. PubMed ID: 8580897
[TBL] [Abstract][Full Text] [Related]
22. Deficiency of interleukin-2 production and interleukin-2 receptor expression on peripheral blood leukocytes after phytohemagglutinin stimulation in pemphigus.
Kermani-Arab V; Hirji K; Ahmed AR; Fahey JL
J Invest Dermatol; 1984 Aug; 83(2):101-4. PubMed ID: 6432916
[TBL] [Abstract][Full Text] [Related]
23. Characterization of a T-cell determinant defined by a monoclonal antibody (TH5.2) which is involved in the interleukin-2-producing and proliferative capabilities of T cells.
Yoshihara PH; Thieme T; Finke P; Barney C; Tong A; Burger DR
Cell Immunol; 1987 Aug; 108(1):10-27. PubMed ID: 3111721
[TBL] [Abstract][Full Text] [Related]
24. In vitro interleukin-5 production of peripheral blood mononuclear cells is increased in patients with asthma.
Endo H; Iwamoto I; Nakajima H; Yoshida S
Int Arch Allergy Immunol; 1993; 101(4):425-30. PubMed ID: 8353463
[TBL] [Abstract][Full Text] [Related]
25. IL-12 and IL-2 potentiate the in vitro tumor-specific activity of peripheral blood cells from cervical cancer patients.
Verma V; Sharma V; Shrivastava SK; Nadkarni JJ
J Exp Clin Cancer Res; 2000 Sep; 19(3):367-74. PubMed ID: 11144531
[TBL] [Abstract][Full Text] [Related]
26. Effect of wheat germ agglutinin on the interleukin pathway of human T lymphocyte activation.
Reed JC; Robb RJ; Greene WC; Nowell PC
J Immunol; 1985 Jan; 134(1):314-23. PubMed ID: 3917278
[TBL] [Abstract][Full Text] [Related]
27. High serum levels of soluble IL-2 receptor, cytokines, and C reactive protein correlate with impairment of T cell response in patients with advanced epithelial ovarian cancer.
Macciò A; Lai P; Santona MC; Pagliara L; Melis GB; Mantovani G
Gynecol Oncol; 1998 Jun; 69(3):248-52. PubMed ID: 9648596
[TBL] [Abstract][Full Text] [Related]
28. [Variations in the level of immunosuppressive acidic protein in patients with gynecologic tumors and pregnant women].
Sawada M; Okudaira Y; Matsui Y; Miyoshi Y; Takayama K; Shimizu Y; Miura S
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1823-30. PubMed ID: 6882005
[TBL] [Abstract][Full Text] [Related]
29. Comparison of interferon-gamma and interleukin-4 production by peripheral blood mononuclear cells and isolated T cells after activation with polyclonal T cell activators.
Gonzalez S; Beck L; Wilson N; Spiegelberg HL
J Clin Lab Anal; 1994; 8(5):277-83. PubMed ID: 7807282
[TBL] [Abstract][Full Text] [Related]
30. Effect of stress on interleukin-2 receptor expression by bovine mononuclear leukocytes.
Lan HC; Reddy PG; Chambers MA; Walker G; Srivastava KK; Ferguson JA
Vet Immunol Immunopathol; 1995 Dec; 49(3):241-9. PubMed ID: 8746698
[TBL] [Abstract][Full Text] [Related]
31. Restoration of functional defects in peripheral blood mononuclear cells isolated from cancer patients by thiol antioxidants alpha-lipoic acid and N-acetyl cysteine.
Mantovani G; Macciò A; Melis G; Mura L; Massa E; Mudu MC
Int J Cancer; 2000 Jun; 86(6):842-7. PubMed ID: 10842199
[TBL] [Abstract][Full Text] [Related]
32. [Effects of cimetidine and PSK on interleukin-2 production by PBL in patients with advanced ovarian carcinoma during the course of chemotherapy].
Kikuchi Y; Kizawa I; Oomori K; Iwano I; Kita T; Miyauchi M; Kato K
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):1987-92. PubMed ID: 3501452
[TBL] [Abstract][Full Text] [Related]
33. NK cell activity in the presence of IL-12 is a prognostic assay to neoadjuvant chemotherapy in cervical cancer.
Cosiski Marana HR; Santana da Silva J; Moreira de Andrade J
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):318-23. PubMed ID: 10985887
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-4 receptors on human blood mononuclear cells.
Zuber CE; Galizzi JP; Harada N; Durand I; Banchereau J
Cell Immunol; 1990 Sep; 129(2):329-40. PubMed ID: 2383894
[TBL] [Abstract][Full Text] [Related]
35. [Expression of interleukin 2(IL-2) receptor and proliferative response to rIL-2 of peripheral blood mononuclear cells (PBMC) in patients with malignant diseases].
Chen YX
Zhonghua Zhong Liu Za Zhi; 1990 Jul; 12(4):281-3. PubMed ID: 2272264
[TBL] [Abstract][Full Text] [Related]
36. Interleukin 2 (IL 2) relationships with the cancer-related immunodeficiency: in vitro response to exogenous IL 2 by PHA-activated and non PHA-activated peripheral blood mononuclear cells from cancer patients.
Mantovani G; Coiana A; Massidda A; Proto E; Floris C; Macciò A; Pusceddu G; Del Giacco GS
Diagn Clin Immunol; 1987; 5(2):104-11. PubMed ID: 3497733
[TBL] [Abstract][Full Text] [Related]
37. Peripheral blood mononuclear cells from autologous hematopoietic stem cell transplantation recipients produce and respond to IL-12.
Guillaume T; Kubin M; Sekhavat M; Rubinstein DB; Trinchieri G; Symann M
Bone Marrow Transplant; 1996 Oct; 18(4):733-9. PubMed ID: 8899188
[TBL] [Abstract][Full Text] [Related]
38. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection.
O'Sullivan ST; Lederer JA; Horgan AF; Chin DH; Mannick JA; Rodrick ML
Ann Surg; 1995 Oct; 222(4):482-90; discussion 490-2. PubMed ID: 7574928
[TBL] [Abstract][Full Text] [Related]
39. Prostaglandin E2 inhibits human T-cell proliferation after crosslinking of the CD3-Ti complex by directly affecting T cells at an early step of the activation process.
Vercammen C; Ceuppens JL
Cell Immunol; 1987 Jan; 104(1):24-36. PubMed ID: 2948675
[TBL] [Abstract][Full Text] [Related]
40. Relationships betxween Fas expression, activation molecule CD25, and functional activity of tumor-associated lymphomonocytes from neoplastic effusions.
Mantovani G; Macciò A; Massa E; Lai P; Manca G; Mudu C; Versace R; Pusceddu G
Oncol Rep; 1999; 6(1):235-9. PubMed ID: 9864435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
